Abstract Background: Breast cancer in Egypt is the most common cancer among women and is the leading cause of cancer mortality. Traditionally, axillary lymph node involvement is considered among the most important prognostic factors in breast cancer. Nonetheless, accumulating evidence suggests that axillary lymph node ratio should be considered as an alternative to classical pN classification.
Background
In Egypt, breast cancer is estimated to be the most common cancer among females accounting for 37.7% of their total with 12,621 new cases in 2008. It is also the leading cause of cancer related mortality accounting for 29.1% of their total with 6546 deaths [1] . These estimates are confirmed in many regional Egyptian cancer registries [2, 3] .
There are variations in breast cancer patterns between developed and developing countries. Higher tumor stage at diagnosis due to the lack of widely implemented national screening programs in Egypt just started few years ago [4] . Also younger age is perhaps more seen in developing nations too and this could be well explained by the different population pyramids being predominantly young in the developing countries [5] .
Traditionally, axillary lymph node involvement and the increasing absolute number of positive lymph nodes (pN) are considered among the most important prognostic factors in breast cancer [6] [7] [8] . Nonetheless, in a recent report using the Geneva Cancer Registry data, the authors established that certain identified cutoff points for axillary lymph node ratio (LNR; ratio of positive over excised lymph nodes) predicted breast cancer survival more accurately than the classical pN classification [9] . The report recommended that LNR should be considered as an alternative to the pN staging. Similarly, a systematic review of 24 articles including 32,299 patients, also concluded that the LNR was superior to the number of involved nodes as a prognostic indicator [10] . New evidence has continued to accrue confirming the prognostic significance of nodal ratios in various worldwide population settings [11] . The analysis of the survival outcome of mostly young patients with early breast cancer in Saudi Arabia identified the adverse prognostic effects of young age, high grade of tumor and intermediate and high LNR on DFS [12] . Prompted by these reports and influenced by the above allotted differences in breast cancer patterns in Egypt compared with that in Western countries, we planned this analysis to examine the prognostic role of LNR on disease free survival (primary objective) and overall survival (secondary objective) of patients with breast cancer. We also intended to highlight the clinicopathologic features of breast cancer in our locality.
Materials and methods
We conducted a retrospective review of 1290 breast cancer patients treated at the Oncology center, Mansoura University between April 2006 and May 2012. Data were retrieved from the electronic hospital-based cancer registry database of the Department of Oncology at Mansoura University Oncology Center, Mansoura, Egypt, until May 2013. Only patients with invasive non-metastatic breast cancer, who underwent axillary lymph node dissection and had one or more positive axillary lymph nodes, were considered eligible. Patients must not have received neoadjuvant chemotherapy. The final number available was 500 patients, representing the study population.
A database was constructed to record the following information for each patient: patient characteristics, diagnostic methods, histological features of the tumor including immunohistochemistry, number of dissected and positive lymph nodes, LNR, treatment details, recurrence data, survival, and cause of death. For the survival analysis, we used the LNR cutoff values as identified by Vinh-Hung et al. [9] . The endpoints for the survival analyses were disease-free (DFS) and overall survival (OS). For patients who were lost to follow-up, their survival status at last contact was used.
Definitions
Disease stage was defined according to the criteria laid down by the International Union Against Cancer, with group clinical and pathological staging according to the American Joint Committee on Cancer. OS was estimated from date of diagnosis to date of last follow-up or death from breast cancer. DFS was defined as the time between date of surgery and date of last follow-up or date of best available evidence of the first unfavorable event: local recurrence, locoregional recurrence, distant metastases, or death. Loco-regional recurrence was defined as any recurrence in the ipsilateral, chest wall, or lymph node. Contralateral breast recurrence was considered as distant metastases.
Statistical methods
Survival functions were estimated applying the method of Kaplan and Meier [13] , while the statistical procedure of Brookmeyer-Crowley was used to estimate the 95% confidence interval (CI) of median survival [14] . The log-rank test was used to assess the significance of unadjusted differences in survival [15] . Exploring variables for their independent prognostic effect on survival was carried out using the multivariate stepwise Cox's proportional regression hazard model [16, 17] , and the goodness of fit was judged by plotting the cumulative baseline hazard function for residuals [18] . We also compared the survival functions for variables after stratifying for baseline differences in additional variables [19] . A two-tailed p value of <0.05 was considered statistically significant. The software IBM-SPSS version 20 was used for all statistical evaluations. The study was approved by the Institutional Review Board.
Results
Five-hundred patients were considered eligible for the analysis. None of the patients had sentinel node procedure. Table 1 depicts patient and disease characteristics. The mean age was 50 years, with 12% (60 patients) and 88% (440 patients) below and above 35 years, respectively. Patients in this series showed a relatively high prevalence of poor prognostic features: 90.6% had more than T1 tumor, 92.8% presented with grade 2 or 3 tumors, 63% and 30.4% had 4 or more and 10 or more positive lymph nodes respectively, around 34.3% had negative ER, and 70% had intermediate or high LNR. Moreover, the median tumor size was 3.7 cm, with 24% and 8% of patients having tumor P5 and P10 cm, respectively.
The median follow-up was 35 months (95% CI 32-37 months), the minimum follow up was 12 months while the maximum follow up was 82 months.
Disease-free survival
The median DFS was 49 months (95% CI 46.4-52.2 months). Table 2 shows the univariate analysis of the influence of various factors on DFS. Patient age 635 years, T2, T3 or T4 tumor, tumor that was grade 2 or 3, tumor that was N2 or N3, tumor with intermediate or high LNR, and ER or PR negative tumors were adversely associated with inferior DFS. The LNR delineates DFS differences between the three risk categories (Fig. 1) . Variables found significant in the univariate analysis were tested in the multivariate Cox regression analysis. Table 3 shows that grade 3 tumors, ER negativity, and the intermediate and high LNR categories were the only variables that were independently associated with adverse DFS. In that multivariate analysis, compared with patients within the low LNR risk group, the hazard ratio of breast cancer recurrence risk was 2.2 (95% CI 1.5-4.9) for patients in the intermediate LNR risk group and 3.2 (95% CI 1.9-5.5) for patients within the high LNR risk group. Classifying patients according to pN1, pN2, or pN3 status was not predictive for DFS.
Overall survival
The OS of the 500 patients in this series was 69 months (95% CI 60-77). Only ER Àve tumor was shown to adversely influence OS with 2-fold (95% CI 1.4-2.9), an increase in the risk of dying of breast cancer.
Discussion
Recognizing that axillary lymph node status is the most powerful predictor of outcome for women with breast cancer [6, 7] , the new American Joint Committee on Breast Cancer staging group patients with increasing absolute number of positive nodes into increasingly higher nodal stages: pathologic pN1, one to three positive nodes; pN2, four to nine positive nodes; pN3, 10 or more positive nodes [8] . Thus, the likelihood of finding all of the positive nodes in the axilla is dependent on the extent of axillary dissection and the extent of pathologic examination. There is evidence that the likelihood of finding positive nodes in the axilla increases with the number of nodes removed. Therefore, in the current staging system, the prognostic value of the absolute number of nodes removed for predicting disease burden in the axilla is confounded by the number of nodes removed.
In a developing country like Egypt, a proportion of breast surgeries was performed at low-volume community hospitals with less than optimal axillary lymph nodes retrieval [20] . In our series where some patients are operated prior to referral to our center, 93 cases (18.4%) had inadequate axillary dissection, i.e. <10 lymph nodes. LNR may be considered as an alternative prognostic factor that may overcome that limitation. The utility of this variable has been tested and proven in several published reports and summarized in the meta-analysis of Woodward et al. [10] .
In exploring the prognostic value of LNR in our series, we elected to use the same cutoff points identified by Vinh-Hung et al. [9] , despite as the authors indicated, that different authors have used different cutoff points to classify patients into several risk groups [21] [22] [23] . In the current series, LNR together with ER negativity and tumor grade were the only factors that were found to influence DFS in the multivariate analysis. Patients with intermediate and high LNRs were associated with a hazard ratio of recurrence of 2.2 and 3.2, respectively as compared with those in the low risk category.
Analysis of the OS only identified ER-tumor as the only prognostic factor associated with an increased risk of dying from breast cancer. It is conceivable that the infrequent number of deaths, so far, may account of the failure of identifying the prognostic value of other variables. Perhaps, reanalysis of this series after a longer follow-up may reveal the influence of additional variables. This was clear in a similar retrospective Lebanese study that included patients diagnosed with breast cancer over a longer period (21 years). On univariate analysis, both the absolute number of positive lymph nodes and the LNR were significant predictors of OS. On multivariate analysis, only the LNR remained an independent predictor of OS, with a 2.5-fold increased risk of dying at an LNR of P0.25 [24] .
Conclusion
The analysis of survival outcome of Egyptian patients with early breast cancer identified the adverse prognostic effects of high tumor grade, ER negativity, and intermediate and high LNR on DFS. Our findings reinforce the importance of LNR rather than the pN staging as an important prognostic variable in breast cancer and it may replace the use of absolute number of axillary lymph nodes.
